 | • レポートコード：MRC2102QY1839 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のバイオ医薬品緩衝剤市場について種類別（リン酸塩タイプ、アセテートタイプ、TRISタイプ、その他）、用途別（研究機関、製薬業、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・バイオ医薬品緩衝剤市場の概要 ・世界の主要地域別バイオ医薬品緩衝剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のバイオ医薬品緩衝剤市場規模2015-2026：種類別（リン酸塩タイプ、アセテートタイプ、TRISタイプ、その他） ・世界のバイオ医薬品緩衝剤市場規模2015-2026：用途別（研究機関、製薬業、その他） ・バイオ医薬品緩衝剤の米国市場規模2015-2020 ・バイオ医薬品緩衝剤のヨーロッパ市場規模2015-2020 ・バイオ医薬品緩衝剤の中国市場規模2015-2020 ・バイオ医薬品緩衝剤の日本市場規模2015-2020 ・バイオ医薬品緩衝剤の東南アジア市場規模2015-2020 ・バイオ医薬品緩衝剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・バイオ医薬品緩衝剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・バイオ医薬品緩衝剤の市場動向・機会・課題 ・調査の結論 |
A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.
The key players are Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE, Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL and so on. According to the revenue of these companies, we can know that the Bio Pharma Buffer industry is relative concentrated. Because the top 6 companies have more than 70% market share in 2017.
Market Analysis and Insights: Global Bio Pharma Buffer Market
The global Bio Pharma Buffer market size is projected to reach US$ 1292.7 million by 2026, from US$ 851.8 million in 2020, at a CAGR of 7.2% during 2021-2026.
Global Bio Pharma Buffer Scope and Market Size
The global Bio Pharma Buffer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bio Pharma Buffer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Bio Pharma Buffer market is segmented into
Phosphates Type
Acetates Type
TRIS Type
Others
Segment by Application, the Bio Pharma Buffer market is segmented into
Research Institution
Pharmaceutical Industry
Others
The Bio Pharma Buffer market is analysed and market size information is provided by regions (countries). Segment by Application, the Bio Pharma Buffer market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Bio Pharma Buffer Market Share Analysis
Bio Pharma Buffer market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bio Pharma Buffer business, the date to enter into the Bio Pharma Buffer market, Bio Pharma Buffer product introduction, recent developments, etc.
The major vendors covered:
Avantor
Alfa Aesar (Thermo Fisher)
Merck
Lonza
Bio-Rad
BD
GE Healthcare
Promega Corporation
Hamilton Company
XZL BIO-TECHNOLOGY
SRL
1 Bio Pharma Buffer Market Overview
1.1 Bio Pharma Buffer Product Scope
1.2 Bio Pharma Buffer Segment by Type
1.2.1 Global Bio Pharma Buffer Sales by Type (2020-2026)
1.2.2 Phosphates Type
1.2.3 Acetates Type
1.2.4 TRIS Type
1.2.5 Others
1.3 Bio Pharma Buffer Segment by Application
1.3.1 Global Bio Pharma Buffer Sales Comparison by Application (2020-2026)
1.3.2 Research Institution
1.3.3 Pharmaceutical Industry
1.3.4 Others
1.4 Bio Pharma Buffer Market Estimates and Forecasts (2015-2026)
1.4.1 Global Bio Pharma Buffer Sales Growth Rate (2015-2026)
1.4.2 Global Bio Pharma Buffer Revenue and Growth Rate (2015-2026)
1.4.3 Global Bio Pharma Buffer Price Trends (2015-2026)
2 Bio Pharma Buffer Estimate and Forecast by Region
2.1 Global Bio Pharma Buffer Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Bio Pharma Buffer Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Bio Pharma Buffer Sales Market Share by Region (2015-2020)
2.2.2 Global Bio Pharma Buffer Revenue Market Share by Region (2015-2020)
2.3 Global Bio Pharma Buffer Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Bio Pharma Buffer Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Bio Pharma Buffer Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Bio Pharma Buffer Estimates and Projections (2015-2026)
2.4.2 Europe Bio Pharma Buffer Estimates and Projections (2015-2026)
2.4.3 China Bio Pharma Buffer Estimates and Projections (2015-2026)
2.4.4 Japan Bio Pharma Buffer Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Bio Pharma Buffer Estimates and Projections (2015-2026)
2.4.6 India Bio Pharma Buffer Estimates and Projections (2015-2026)
3 Global Bio Pharma Buffer Competition Landscape by Players
3.1 Global Top Bio Pharma Buffer Players by Sales (2015-2020)
3.2 Global Top Bio Pharma Buffer Players by Revenue (2015-2020)
3.3 Global Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio Pharma Buffer as of 2019)
3.4 Global Bio Pharma Buffer Average Price by Company (2015-2020)
3.5 Manufacturers Bio Pharma Buffer Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Bio Pharma Buffer Players (Opinion Leaders)
4 Global Bio Pharma Buffer Market Size by Type
4.1 Global Bio Pharma Buffer Historic Market Review by Type (2015-2020)
4.1.1 Global Bio Pharma Buffer Sales Market Share by Type (2015-2020)
4.1.2 Global Bio Pharma Buffer Revenue Market Share by Type (2015-2020)
4.1.3 Global Bio Pharma Buffer Price by Type (2015-2020)
4.2 Global Bio Pharma Buffer Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Bio Pharma Buffer Sales Forecast by Type (2021-2026)
4.2.2 Global Bio Pharma Buffer Revenue Forecast by Type (2021-2026)
4.2.3 Global Bio Pharma Buffer Price Forecast by Type (2021-2026)
5 Global Bio Pharma Buffer Market Size by Application
5.1 Global Bio Pharma Buffer Historic Market Review by Application (2015-2020)
5.1.1 Global Bio Pharma Buffer Sales Market Share by Application (2015-2020)
5.1.2 Global Bio Pharma Buffer Revenue Market Share by Application (2015-2020)
5.1.3 Global Bio Pharma Buffer Price by Application (2015-2020)
5.2 Global Bio Pharma Buffer Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Bio Pharma Buffer Sales Forecast by Application (2021-2026)
5.2.2 Global Bio Pharma Buffer Revenue Forecast by Application (2021-2026)
5.2.3 Global Bio Pharma Buffer Price Forecast by Application (2021-2026)
6 United States Bio Pharma Buffer Market Facts & Figures
6.1 United States Bio Pharma Buffer Sales Market Share by Company (2015-2020)
6.2 United States Bio Pharma Buffer Sales Market Share by Type (2015-2020)
6.3 United States Bio Pharma Buffer Sales Market Share by Application (2015-2020)
7 Europe Bio Pharma Buffer Market Facts & Figures
7.1 Europe Bio Pharma Buffer Sales Market Share by Company (2015-2020)
7.2 Europe Bio Pharma Buffer Sales Market Share by Type (2015-2020)
7.3 Europe Bio Pharma Buffer Sales Market Share by Application (2015-2020)
8 China Bio Pharma Buffer Market Facts & Figures
8.1 China Bio Pharma Buffer Sales Market Share by Company (2015-2020)
8.2 China Bio Pharma Buffer Sales Market Share by Type (2015-2020)
8.3 China Bio Pharma Buffer Sales Market Share by Application (2015-2020)
9 Japan Bio Pharma Buffer Market Facts & Figures
9.1 Japan Bio Pharma Buffer Sales Market Share by Company (3015-3030)
9.2 Japan Bio Pharma Buffer Sales Market Share by Type (2015-2020)
9.3 Japan Bio Pharma Buffer Sales Market Share by Application (2015-2020)
10 Southeast Asia Bio Pharma Buffer Market Facts & Figures
10.1 Southeast Asia Bio Pharma Buffer Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Bio Pharma Buffer Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Bio Pharma Buffer Sales Market Share by Application (2015-2020)
11 India Bio Pharma Buffer Market Facts & Figures
11.1 India Bio Pharma Buffer Sales Market Share by Company (2015-2020)
11.2 India Bio Pharma Buffer Sales Market Share by Type (2015-2020)
11.3 India Bio Pharma Buffer Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Bio Pharma Buffer Business
12.1 Avantor
12.1.1 Avantor Corporation Information
12.1.2 Avantor Business Overview
12.1.3 Avantor Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Avantor Bio Pharma Buffer Products Offered
12.1.5 Avantor Recent Development
12.2 Alfa Aesar (Thermo Fisher)
12.2.1 Alfa Aesar (Thermo Fisher) Corporation Information
12.2.2 Alfa Aesar (Thermo Fisher) Business Overview
12.2.3 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Products Offered
12.2.5 Alfa Aesar (Thermo Fisher) Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck Bio Pharma Buffer Products Offered
12.3.5 Merck Recent Development
12.4 Lonza
12.4.1 Lonza Corporation Information
12.4.2 Lonza Business Overview
12.4.3 Lonza Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Lonza Bio Pharma Buffer Products Offered
12.4.5 Lonza Recent Development
12.5 Bio-Rad
12.5.1 Bio-Rad Corporation Information
12.5.2 Bio-Rad Business Overview
12.5.3 Bio-Rad Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Bio-Rad Bio Pharma Buffer Products Offered
12.5.5 Bio-Rad Recent Development
12.6 BD
12.6.1 BD Corporation Information
12.6.2 BD Business Overview
12.6.3 BD Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020)
12.6.4 BD Bio Pharma Buffer Products Offered
12.6.5 BD Recent Development
12.7 GE Healthcare
12.7.1 GE Healthcare Corporation Information
12.7.2 GE Healthcare Business Overview
12.7.3 GE Healthcare Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020)
12.7.4 GE Healthcare Bio Pharma Buffer Products Offered
12.7.5 GE Healthcare Recent Development
12.8 Promega Corporation
12.8.1 Promega Corporation Corporation Information
12.8.2 Promega Corporation Business Overview
12.8.3 Promega Corporation Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Promega Corporation Bio Pharma Buffer Products Offered
12.8.5 Promega Corporation Recent Development
12.9 Hamilton Company
12.9.1 Hamilton Company Corporation Information
12.9.2 Hamilton Company Business Overview
12.9.3 Hamilton Company Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Hamilton Company Bio Pharma Buffer Products Offered
12.9.5 Hamilton Company Recent Development
12.10 XZL BIO-TECHNOLOGY
12.10.1 XZL BIO-TECHNOLOGY Corporation Information
12.10.2 XZL BIO-TECHNOLOGY Business Overview
12.10.3 XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020)
12.10.4 XZL BIO-TECHNOLOGY Bio Pharma Buffer Products Offered
12.10.5 XZL BIO-TECHNOLOGY Recent Development
12.11 SRL
12.11.1 SRL Corporation Information
12.11.2 SRL Business Overview
12.11.3 SRL Bio Pharma Buffer Sales, Revenue and Gross Margin (2015-2020)
12.11.4 SRL Bio Pharma Buffer Products Offered
12.11.5 SRL Recent Development
13 Bio Pharma Buffer Manufacturing Cost Analysis
13.1 Bio Pharma Buffer Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Bio Pharma Buffer
13.4 Bio Pharma Buffer Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Bio Pharma Buffer Distributors List
14.3 Bio Pharma Buffer Customers
15 Market Dynamics
15.1 Bio Pharma Buffer Market Trends
15.2 Bio Pharma Buffer Opportunities and Drivers
15.3 Bio Pharma Buffer Market Challenges
15.4 Bio Pharma Buffer Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Bio Pharma Buffer Sales (kL) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Bio Pharma Buffer Sales (kL) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Bio Pharma Buffer Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Bio Pharma Buffer Sales (kL) by Region (2015-2020)
Table 5. Global Bio Pharma Buffer Sales Market Share by Region (2015-2020)
Table 6. Global Bio Pharma Buffer Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Bio Pharma Buffer Revenue Share by Region (2015-2020)
Table 8. Global Bio Pharma Buffer Sales (kL) Forecast by Region (2021-2026)
Table 9. Global Bio Pharma Buffer Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Bio Pharma Buffer Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Bio Pharma Buffer Revenue Share Forecast by Region (2021-2026)
Table 12. Global Bio Pharma Buffer (kL) of Key Companies (2015-2020)
Table 13. Global Bio Pharma Buffer Sales Share by Company (2015-2020)
Table 14. Global Bio Pharma Buffer Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Bio Pharma Buffer Revenue Share by Company (2015-2020)
Table 16. Global Bio Pharma Buffer by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio Pharma Buffer as of 2019)
Table 17. Global Bio Pharma Buffer Average Price (USD/L) of Key Company (2015-2020)
Table 18. Manufacturers Bio Pharma Buffer Manufacturing Sites and Area Served
Table 19. Manufacturers Bio Pharma Buffer Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Bio Pharma Buffer Players
Table 22. Global Bio Pharma Buffer Sales (kL) by Type (2015-2020)
Table 23. Global Bio Pharma Buffer Sales Share by Type (2015-2020)
Table 24. Global Bio Pharma Buffer Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Bio Pharma Buffer Price (kL) by Type (2015-2020)
Table 26. Global Bio Pharma Buffer Sales Share by Type (2021-2026)
Table 27. Global Bio Pharma Buffer Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Bio Pharma Buffer Revenue Share by Type (2021-2026)
Table 29. Global Bio Pharma Buffer Price (kL) by Type (2021-2026)
Table 30. Global Bio Pharma Buffer Sales (kL) by Application (2015-2020)
Table 31. Global Bio Pharma Buffer Sales Share by Application (2015-2020)
Table 32. Global Bio Pharma Buffer Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Bio Pharma Buffer Price (kL) by Application (2015-2020)
Table 34. Global Bio Pharma Buffer Sales (kL) by Application (2021-2026)
Table 35. Global Bio Pharma Buffer Sales Share by Application (2021-2026)
Table 36. Global Bio Pharma Buffer Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Bio Pharma Buffer Revenue Share by Application (2021-2026)
Table 38. Global Bio Pharma Buffer Price (kL) by Application (2021-2026)
Table 39. United States Bio Pharma Buffer Sales (kL) by Company (2015-2020)
Table 40. United States Bio Pharma Buffer Sales Market Share by Company (2015-2020)
Table 41. United States Bio Pharma Buffer Sales (kL) by Type (2015-2020)
Table 42. United States Bio Pharma Buffer Sales Market Share by Type (2015-2020)
Table 43. United States Bio Pharma Buffer Sales (kL) by Application (2015-2020)
Table 44. United States Bio Pharma Buffer Sales Market Share by Application (2015-2020)
Table 45. Europe Bio Pharma Buffer Sales (kL) by Company (2015-2020)
Table 46. Europe Bio Pharma Buffer Sales Market Share by Company (2015-2020)
Table 47. Europe Bio Pharma Buffer Sales (kL) by Type (2015-2020)
Table 48. Europe Bio Pharma Buffer Sales Market Share by Type (2015-2020)
Table 49. Europe Bio Pharma Buffer Sales (kL) by Application (2015-2020)
Table 50. Europe Bio Pharma Buffer Sales Market Share by Type (2015-2020)
Table 51. China Bio Pharma Buffer Sales (kL) by Company (2015-2020)
Table 52. China Bio Pharma Buffer Sales Market Share by Company (2015-2020)
Table 53. China Bio Pharma Buffer Sales (kL) by Type (2015-2020)
Table 54. China Bio Pharma Buffer Sales Market Share by Type (2015-2020)
Table 55. China Bio Pharma Buffer Sales (kL) by Application (2015-2020)
Table 56. China Bio Pharma Buffer Sales Market Share by Application (2015-2020)
Table 57. Japan Bio Pharma Buffer Sales (kL) by Company (2015-2020)
Table 58. Japan Bio Pharma Buffer Sales Market Share by Company (2015-2020)
Table 59. Japan Bio Pharma Buffer Sales (kL) by Type (2015-2020)
Table 60. Japan Bio Pharma Buffer Sales Market Share by Type (2015-2020)
Table 61. Japan Bio Pharma Buffer Sales (kL) by Application (2015-2020)
Table 62. Japan Bio Pharma Buffer Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Bio Pharma Buffer Sales (kL) by Company (2015-2020)
Table 64. Southeast Asia Bio Pharma Buffer Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Bio Pharma Buffer Sales (kL) by Type (2015-2020)
Table 66. Southeast Asia Bio Pharma Buffer Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Bio Pharma Buffer Sales (kL) by Type (2015-2020)
Table 68. Southeast Asia Bio Pharma Buffer Sales Market Share by Application (2015-2020)
Table 69. India Bio Pharma Buffer Sales (kL) by Company (2015-2020)
Table 70. India Bio Pharma Buffer Sales Market Share by Company (2015-2020)
Table 71. India Bio Pharma Buffer Sales (kL) by Type (2015-2020)
Table 72. India Bio Pharma Buffer Sales Market Share by Type (2015-2020)
Table 73. India Bio Pharma Buffer Sales (kL) by Application (2015-2020)
Table 74. India Bio Pharma Buffer Sales Market Share by Application (2015-2020)
Table 75. Avantor Corporation Information
Table 76. Avantor Description and Business Overview
Table 77. Avantor Bio Pharma Buffer Sales (kL), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 78. Avantor Bio Pharma Buffer Product
Table 79. Avantor Recent Development
Table 80. Alfa Aesar (Thermo Fisher) Corporation Information
Table 81. Alfa Aesar (Thermo Fisher) Description and Business Overview
Table 82. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales (kL), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 83. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Product
Table 84. Alfa Aesar (Thermo Fisher) Recent Development
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Bio Pharma Buffer Sales (kL), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 88. Merck Bio Pharma Buffer Product
Table 89. Merck Recent Development
Table 90. Lonza Corporation Information
Table 91. Lonza Description and Business Overview
Table 92. Lonza Bio Pharma Buffer Sales (kL), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 93. Lonza Bio Pharma Buffer Product
Table 94. Lonza Recent Development
Table 95. Bio-Rad Corporation Information
Table 96. Bio-Rad Description and Business Overview
Table 97. Bio-Rad Bio Pharma Buffer Sales (kL), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 98. Bio-Rad Bio Pharma Buffer Product
Table 99. Bio-Rad Recent Development
Table 100. BD Corporation Information
Table 101. BD Description and Business Overview
Table 102. BD Bio Pharma Buffer Sales (kL), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 103. BD Bio Pharma Buffer Product
Table 104. BD Recent Development
Table 105. GE Healthcare Corporation Information
Table 106. GE Healthcare Description and Business Overview
Table 107. GE Healthcare Bio Pharma Buffer Sales (kL), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 108. GE Healthcare Bio Pharma Buffer Product
Table 109. GE Healthcare Recent Development
Table 110. Promega Corporation Corporation Information
Table 111. Promega Corporation Bio Pharma Buffer Sales (kL), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 112. Promega Corporation Description and Business Overview
Table 113. Promega Corporation Bio Pharma Buffer Product
Table 114. Promega Corporation Recent Development
Table 115. Hamilton Company Corporation Information
Table 116. Hamilton Company Bio Pharma Buffer Sales (kL), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 117. Hamilton Company Description and Business Overview
Table 118. Hamilton Company Bio Pharma Buffer Product
Table 119. Hamilton Company Recent Development
Table 120. XZL BIO-TECHNOLOGY Corporation Information
Table 121. XZL BIO-TECHNOLOGY Description and Business Overview
Table 122. XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales (kL), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 123. XZL BIO-TECHNOLOGY Bio Pharma Buffer Product
Table 124. XZL BIO-TECHNOLOGY Recent Development
Table 125. SRL Corporation Information
Table 126. SRL Description and Business Overview
Table 127. SRL Bio Pharma Buffer Sales (kL), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 128. SRL Bio Pharma Buffer Product
Table 129. SRL Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Bio Pharma Buffer Distributors List
Table 133. Bio Pharma Buffer Customers List
Table 134. Bio Pharma Buffer Market Key Trends
Table 135. Bio Pharma Buffer Key Opportunities and Drivers
Table 136. Bio Pharma Buffer Market Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Bio Pharma Buffer Product Picture
Figure 2. Global Bio Pharma Buffer Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Bio Pharma Buffer Market Share by Application in 2020 & 2026
Figure 6. Research Institution Examples
Figure 7. Pharmaceutical Industry Examples
Figure 8. Others Examples
Figure 9. Global Bio Pharma Buffer Sales (kL) Growth Rate (2015-2026)
Figure 10. Global Bio Pharma Buffer Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Bio Pharma Buffer Price Trends Growth Rate (2015-2026) (USD/L)
Figure 12. Global Bio Pharma Buffer Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Bio Pharma Buffer Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Bio Pharma Buffer Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Bio Pharma Buffer Sales (kL) Growth Rate (2015-2026)
Figure 16. Europe Bio Pharma Buffer Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Bio Pharma Buffer Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Bio Pharma Buffer Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Bio Pharma Buffer Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Bio Pharma Buffer Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Bio Pharma Buffer Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Bio Pharma Buffer Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Bio Pharma Buffer Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Bio Pharma Buffer Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Bio Pharma Buffer Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Bio Pharma Buffer Players Market Share by Revenue in Bio Pharma Buffer 2015 & 2019
Figure 27. Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Bio Pharma Buffer Revenue Share by Type (2015-2020)
Figure 29. Global Bio Pharma Buffer Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Bio Pharma Buffer Revenue Share by Application (2015-2020)
Figure 31. Global Bio Pharma Buffer Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Bio Pharma Buffer Sales Market Share by Type in 2019
Figure 33. United States Bio Pharma Buffer Sales Market Share by Type in 2019
Figure 34. Europe Bio Pharma Buffer Sales Market Share by Company in 2019
Figure 35. Europe Bio Pharma Buffer Sales Market Share by Type in 2019
Figure 36. Europe Bio Pharma Buffer Sales Market Share by Application in 2019
Figure 37. China Bio Pharma Buffer Sales Market Share by Company in 2019
Figure 38. China Bio Pharma Buffer Sales Market Share by Type in 2019
Figure 39. China Bio Pharma Buffer Sales Market Share by Application in 2019
Figure 40. Japan Bio Pharma Buffer Sales Market Share by Company in 2019
Figure 41. Japan Bio Pharma Buffer Sales Market Share by Type in 2019
Figure 42. Japan Bio Pharma Buffer Sales Market Share by Application in 2019
Figure 43. Southeast Asia Bio Pharma Buffer Sales Market Share by Company in 2019
Figure 44. Southeast Asia Bio Pharma Buffer Sales Market Share by Type in 2019
Figure 45. Southeast Asia Bio Pharma Buffer Sales Market Share by Application in 2019
Figure 46. India Bio Pharma Buffer Sales Market Share by Company in 2019
Figure 47. India Bio Pharma Buffer Sales Market Share by Type in 2019
Figure 48. India Bio Pharma Buffer Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Bio Pharma Buffer
Figure 51. Manufacturing Process Analysis of Bio Pharma Buffer
Figure 52. Bio Pharma Buffer Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
ステンレス鋼バッファタンクの世界市場レポート2020 Buffer Tanks for chilled & thermal water increase system capacity and stabilize return water temperature. Benefits include fewer cycles of the compressor and better temperature control. Lochinvar Products was the greatest company in Stainless Steel Buffer Tank industry in United States, with the sal…- 冷水緩衝タンクの世界市場レポート2020 Chilled Water Buffer Tanks (CBT) are designed for chilled water systems with insufficient water volume capacity, in relation to the chiller capacity. Chilled Water Buffer Tanks are essential components in modern day chiller systems. Market Analysis and Insights: Global Chilled Water Buffer Tanks Mar…
- 製薬用エチルマロネートの世界市場レポート2020 Market Analysis and Insights: Global Pharma Grade Ethylmalonate Market The global Pharma Grade Ethylmalonate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Pharma Grade Ethylmalonate Scope and Market Size The global Ph…
- 製薬用ブリスター包装機の世界市場レポート2020 Blister packaging machines seal products in a cavity, usually with a paper backing or aluminum or film seal. These blister packs can be used for just about any product, but are common packages for small consumer goods, foods and pharmaceuticals. This report mainly covers Blister Packaging Machines f…
- イソニアジドの世界市場レポート2020 Market Analysis and Insights: Global Isoniazid Market The global Isoniazid market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Isoniazid Scope and Market Size The global Isoniazid market is segmented by company, region (cou…